Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

The Ulman Foundation, a longstanding staple in the community, recently held a ribbon-cutting for its new brick "Legacy ...

October, just two weeks before her son Salvatore’s wedding, her family wasn’t sure if she would be able to make it to the ...